查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
多發性骨髓瘤治療全球市場研究報告——2023-2030 年行業分析、規模、份額、增長、趨勢和預測
市場調查報告書
商品編碼
1264109

多發性骨髓瘤治療全球市場研究報告——2023-2030 年行業分析、規模、份額、增長、趨勢和預測

Global Multiple Myeloma Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

多發性骨髓瘤與白血病和淋巴瘤一樣，是一種起源於骨髓的血液癌症。 在多發性骨髓瘤中，某些白細胞 (WBC) 開始在骨髓中異常生長。 有多種治療方法可以減緩疾病的進展。 誘導治療是本病的首選治療方法。 然後進行幹細胞移植 (SCT)。 在幹細胞移植中，一台機器取出患者的干細胞並將其冷凍。 然後將細胞移植到患者體內。 還給予化療，包括阿黴素、alkeran、cytoxan、oncovin、pomalyst、revlimid、talomid 和 velcade 等藥物。 蛋白□體抑製劑是多發性骨髓瘤的常見治療方法，可用於疾病的所有階段。

市場動態：

隨著這種疾病在人群中的流行率增加，預計多發性骨髓瘤藥物市場將會增長。 此外，世界上日益嚴重的老齡化人口肯定會推動多發性骨髓瘤藥物市場的發展。 此外，由於新療法的批准和現有藥物的低療效，預計市場將大幅上漲。

這份研究報告解釋了波特的五力模型、市場吸引力分析和價值鏈分析。 這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。 此外，這些工具還提供了對全球多發性骨髓瘤治療市場各個部分的全面評估。 多發性骨髓瘤治療行業的發展和趨勢為這項研究提供了一種整體方法。

市場細分：

多發性骨髓瘤治療市場報告的這一部分提供了國家/地區層面的詳細數據，這有助於戰略制定者確定目標受眾和每種產品或服務的即將到來的機會。支持

按產品類型

  • 化療
  • 輻射
  • 幹細胞移植
  • 其他支持性治療

由最終用戶/應用程序

  • 醫院
  • 診所
  • 其他

按地區分析：

本部分涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲、中東和非洲多發性骨髓瘤治療市場當前和未來的需求。 此外，它還關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。 多發性骨髓瘤治療市場的主要參與者是 Janssen Biotech, Inc.、Bristol-Myers Squibb、Novartis AG、Bristol-Myers Squibb Company、Millennium Pharmaceuticals、Celgene Corporation、Kesios Therapeutics Limited、Amgene, Inc、Genzyme Corporation、Juno Therapeutics。 本節概述了競爭格局，包括各種戰略發展，例如主要併購、未來能力、合作夥伴關係、財務概覽、聯合研究、新產品開發和新產品發布。

內容

第一章前言

  • 報告內容
    • 目的
    • 目標受眾
    • USP（獨特的銷售建議）及其提供的內容
  • 調查範圍
  • 調查方法
    • 市場調研流程
    • 市場研究方法

第 2 章執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章多發性骨髓瘤藥物 - 行業分析

  • 簡介 - 市場動態
  • 市場驅動因素
  • 市場製約因素
  • 機會
  • 行業趨勢
  • 波特的五力分析
  • 市場吸引力分析
    • 按產品類型
    • 最終用戶
    • 按地區

第四章價值鏈分析

  • 價值鏈分析
  • 原材料分析
    • 原材料清單
    • 原材料製造商名單
    • 主要原材料價格走勢
  • 潛在買家名單
  • 營銷渠道
    • 直接營銷
    • 間接營銷
    • 市場發展趨勢

第 5 章 COVID-19 爆發的影響分析

第 6 章全球多發性骨髓瘤藥物市場分析（按產品類型）

  • 摘要：按產品類型
  • 過去和未來的數據
  • 分析：按產品類型
  • 化療市場：按地區
  • 輻射市場：按地區
  • 幹細胞移植市場：按地區
  • 其他支持性護理市場：按地區

第 7 章全球多發性骨髓瘤藥物市場分析：按最終用戶分類

  • 最終用戶總結
  • 過去和未來的數據
  • 最終用戶分析
  • 醫院市場：按地區
  • 診所市場：按地區
  • 其他市場：按地區

第 8 章全球多發性骨髓瘤藥物市場分析：按地區

  • 區域展望
  • 簡介
  • 北美
    • 摘要、實際數據、預測數據
    • 按北美細分
    • 北美：按國家/地區列出
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 摘要、實際數據、預測數據
    • 歐洲（按細分市場）
    • 歐洲：按國家/地區分類
    • 英國
    • 法國
    • 德國
    • 意大利
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 摘要、實際數據、預測數據
    • 按亞太地區細分
    • 亞太地區：國家/地區信息
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 拉丁美洲
    • 摘要、實際數據、預測數據
    • 拉丁美洲細分市場
    • 拉丁美洲：按國家/地區列出
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲地區
  • 中東和非洲
    • 摘要、實際數據、預測數據
    • 中東和非洲分部信息
    • 中東和非洲：按國家/地區列出
    • 沙特阿拉伯
    • 阿聯酋
    • 以色列
    • 南非
    • 其他中東和非洲地區

第9章：多發性骨髓瘤藥物公司的競爭格局

  • 多發性骨髓瘤藥物市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他擴展

第十章公司簡介

  • 公司股票分析
  • 市場集中度
  • 楊森生物技術公司
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 百時美施貴寶
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 諾華公司
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 百時美施貴寶公司
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 千年製藥公司
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 新基公司
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • Kesios Therapeutics Limited
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 安基因公司
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 健贊公司
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 朱諾療法
    • 公司簡介
    • 產品介紹
    • 近期趨勢

注意：在公司簡介、財務細節、近期發展等方面，基於可用信息，私人控股公司可能不包括在內。

Product Code: VMR11216795

Multiple myeloma is a blood cancer similar to leukaemia and lymphoma that develops in the bone marrow. Certain white blood cells (WBCs) begin to grow inappropriately within the bone marrow in multiple myeloma. Different treatments are effective in delaying the disease's progression. Induction therapy is the first treatment for the condition. After that, stem cell transplantation (SCT) is performed. In stem cell transplantation, a machine extracts the patient's stem cells, which are then frozen and stored. Following that, the cells are implanted into the patient's body. Patients are also given chemotherapy, which includes administering medications like Adriamycin, Alkeran, Cytoxan, Oncovin, Pomalyst, Revlimid, Thalomid, and Velcade. Proteasome inhibitors are a common treatment for multiple myeloma and are used at all stages of the disease.

Market Dynamics:

The market for multiple myeloma medicines is predicted to develop as the disease's prevalence among the population rises. In addition, the growing elderly population across the globe will surely boost the market for multiple myeloma medicines. Furthermore, the market is expected to rise substantially due to the approval of newer treatments and the low efficacy of the currently available drugs.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of multiple myeloma therapeutics. The growth and trends of multiple myeloma therapeutics industry provide a holistic approach to this study.

Market Segmentation:

This section of the multiple myeloma therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Chemotherapy
  • Radiation
  • Stem Cell Transplant
  • Other Supportive Treatments

By End Users/Applications

  • Hospitals
  • Clinics
  • Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Multiple Myeloma Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the multiple myeloma therapeutics market include Janssen Biotech, Inc., Bristol-Myers Squibb, Novartis AG, Bristol-Myers Squibb Company, Millennium Pharmaceuticals, Celgene Corporation, Kesios Therapeutics Limited, Amgene, Inc., Genzyme Corporation, Juno Therapeutics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . MULTIPLE MYELOMA THERAPEUTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Product Type
    • 3.7.2 By End Users
    • 3.7.3 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL MULTIPLE MYELOMA THERAPEUTICS MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Chemotherapy Market by Regions
  • 6.6 Radiation Market by Regions
  • 6.5 Stem Cell Transplant Market by Regions
  • 6.7 Other Supportive Treatments Market by Regions

7 . GLOBAL MULTIPLE MYELOMA THERAPEUTICS MARKET ANALYSIS BY END USERS

  • 7.1 Overview by End Users
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End Users
  • 7.4 Hospitals Market by Regions
  • 7.5 Clinics Market by Regions
  • 7.6 Others Market by Regions

8 . GLOBAL MULTIPLE MYELOMA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview, Historic and Forecast Data
    • 8.3.2. North America By Segment
    • 8.3.3. North America By Country
    • 8.3.4. United State
    • 8.3.5. Canada
    • 8.3.6. Mexico
  • 8.4. Europe
    • 8.4.1. Overview, Historic and Forecast Data
    • 8.4.2. Europe by Segment
    • 8.4.3. Europe by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7. Italy
    • 8.4.8. Russia
    • 8.4.9. Rest Of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview, Historic and Forecast Data
    • 8.5.2. Asia Pacific by Segment
    • 8.5.3. Asia Pacific by Country
    • 8.5.4. China
    • 8.5.5. India
    • 8.5.6. Japan
    • 8.5.7. South Korea
    • 8.5.8. Australia
    • 8.5.9. Rest Of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview, Historic and Forecast Data
    • 8.6.2. Latin America by Segment
    • 8.6.3. Latin America by Country
    • 8.6.4. Brazil
    • 8.6.5. Argentina
    • 8.6.6. Peru
    • 8.6.7. Chile
    • 8.6.8. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview, Historic and Forecast Data
    • 8.7.2. Middle East & Africa by Segment
    • 8.7.3. Middle East & Africa by Country
    • 8.7.4. Saudi Arabia
    • 8.7.5. UAE
    • 8.7.6. Israel
    • 8.7.7. South Africa
    • 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE MULTIPLE MYELOMA THERAPEUTICS COMPANIES

  • 9.1. Multiple Myeloma Therapeutics Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF MULTIPLE MYELOMA THERAPEUTICS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Janssen Biotech, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Bristol-Myers Squibb
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Novartis AG
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Bristol-Myers Squibb Company
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Millennium Pharmaceuticals
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Celgene Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Kesios Therapeutics Limited
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Amgene, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financials
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Genzyme Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Financials
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Juno Therapeutics
    • 10.12.1. Company Overview
    • 10.12.2. Financials
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product Type (USD MN)
  • Chemotherapy Market by Geography (USD MN)
  • Radiation Market by Geography (USD MN)
  • Stem Cell Transplant Market by Geography (USD MN)
  • Other Supportive Treatments Market by Geography (USD MN)
  • Analysis Market by End Users (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Clinics Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Multiple Myeloma Therapeutics Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Multiple Myeloma Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Multiple Myeloma Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by End Users
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Chemotherapy Market by Geography (USD MN)
  • Radiation Market by Geography (USD MN)
  • Stem Cell Transplant Market by Geography (USD MN)
  • Other Supportive Treatments Market by Geography (USD MN)
  • Global Market Analysis by End Users (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Clinics Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.